Celecoxib påvirker ikke i klinisk relevant grad farmakokinetikken af tolbutamid (CYP2C9- substrat), eller glibenclamid.
Celecoxib does not affect the pharmacokinetics of tolbutamide (CYP2C9 substrate), or glibenclamide to a clinically relevant extent.